On the other hand, many studies revealed that AVE 0991 as a non-peptide Mas agonist could ameliorate atherosclerosis progression [7], which was associated with a significant reduction of NADPH oxidase expression in ApoE - knockout mice [71]. The gene discussed is MAS1; the disease is atherosclerosis.